Members |
associationTargetComponent |
[D]Umbilical swelling |
Umbilical swelling |
[D]Unattended death |
Unattended death |
[D]Unconsciousness |
Unconscious |
[D]Underweight |
Underweight |
[D]Undue concern and preoccupation with stressful events |
Undue concern and preoccupation with stressful events |
[D]Unhappiness |
Feeling unhappy |
[D]Ureter filling defect |
Ureter filling defect |
[D]Ureteric colic |
Ureteric colic |
[D]Urethral discharge |
Urethral discharge |
[D]Urethral sphincter incontinence |
Urinary incontinence due to urethral sphincter incompetence |
[D]Urethrorrhoea |
Urethral discharge |
[D]Urgency of micturition |
Urgent desire to urinate |
[D]Vaginal fluid abnormal |
Vaginal fluid abnormal |
[D]Vectorcardiogram abnormal |
Vectorcardiogram abnormal |
[D]Verbosity and circumstantial detail obscuring reason for contact |
Verbosity and circumstantial detail obscuring reason for contact |
[D]Very low level of personal hygiene |
Very low level of personal hygiene |
[D]Vesical pain |
Bladder pain |
[D]Vesical tenesmus |
Painful bladder spasm |
[D]Visible peristalsis |
Visible peristalsis |
[D]Visual hallucinations |
Visual hallucinations |
[D]Visually evoked potentials abnormal |
Abnormal visual evoked potential |
[D]Vomiting |
Vomiting |
[D]Wasting disease |
Wasting disease |
[D]Waterbrash |
Waterbrash |
[D]Weak pulse |
Thready pulse |
[D]Weight, failure to gain, infant |
Failure to thrive in infant |
[D]Wheezing |
Wheezing |
[D]Wrist lump |
Mass of wrist |
[D]Yawning |
Yawning |
[D]Zinc, blood level abnormal |
Abnormal zinc level in blood |
[M]Acute myeloid leukaemia |
Acute myeloid leukaemia |
[M]Aleukaemic monocytic leukaemia |
Aleukemic monocytic leukemia |
[M]Angiofibroma NOS |
Angiofibroma |
[M]Chronic leukaemia NOS |
Chronic leukaemia |
[M]Chronic monocytic leukaemia |
Chronic monocytic leukaemia |
[M]Chronic monocytic leukaemia |
Chronic myeloid leukaemia |
[M]Haemangiopericytic neoplasms |
Solitary fibrous tumour |
[M]Malignant melanoma NOS or melanocarcinoma or melanoma NOS |
Malignant melanoma |
[M]Monocytic leukaemia NOS |
Monocytic leukaemia |
[M]Other lymphoid leukaemia NOS |
Lymphoid leukaemia |
[M]Plasmacytoma NOS |
Plasmacytoma |
[M]Subacute monocytic leukaemia |
Subacute monocytic leukaemia |
[M]Subacute monocytic leukaemia |
Subacute monocytic leukaemia |
[X] (Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction) or (organic psychosyndrome) |
Organic mental disorder |
[X] Mental and behavioural disorders due to use of opioids: withdrawal state (& [cold turkey, opiate withdrawal]) |
Opioid withdrawal syndrome |
[X](Overeating associated with other psychological disturbances) or (psychogenic overeating) |
Psychogenic overeating |
abatacept 125 mg / 1 mL injection, 1 mL injection device (medicinal product unit of use) |
Unknown Cell Type 2 |
abatacept 125 mg / 1 mL injection, 4 x 1 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
abatacept 125 mg/mL injection, 4 x 1 mL injection devices |
Unknown Cell Type 2 |
abatacept 125 mg/mL injection, injection device |
Unknown Cell Type 2 |
ascorbic acid + citrus bioflavonoids extract + rutoside + hesperidin + dog rose + acerola |
ascorbic acid + citrus bioflavonoids extract + rutoside + hesperidin + Rosa canina extract + acerola extract |
ascorbic acid 400 mg + calcium ascorbate dihydrate 400 mg + sodium ascorbate 350 mg + citrus bioflavonoids extract 25 mg + rutoside 50 mg + hesperidin 50 mg + dog rose 250 mg + acerola 50 mg tablet |
ascorbic acid 400 mg + calcium ascorbate dihydrate 400 mg + sodium ascorbate 350 mg + citrus bioflavonoids extract 25 mg + rutoside 50 mg + hesperidin 50 mg + Rosa canina extract 250 mg + acerola extract 50 mg tablet |
ascorbic acid 400 mg + calcium ascorbate dihydrate 400 mg + sodium ascorbate 350 mg + citrus bioflavonoids extract 25 mg + rutoside 50 mg + hesperidin 50 mg + dog rose 250 mg + acerola 50 mg tablet, 150 |
ascorbic acid 400 mg + calcium ascorbate dihydrate 400 mg + sodium ascorbate 350 mg + citrus bioflavonoids extract 25 mg + rutoside 50 mg + hesperidin 50 mg + Rosa canina extract 250 mg + acerola extract 50 mg tablet, 150 |
ascorbic acid 400 mg + calcium ascorbate dihydrate 400 mg + sodium ascorbate 350 mg + citrus bioflavonoids extract 25 mg + rutoside 50 mg + hesperidin 50 mg + dog rose 250 mg + acerola 50 mg tablet, 31 |
ascorbic acid 400 mg + calcium ascorbate dihydrate 400 mg + sodium ascorbate 350 mg + citrus bioflavonoids extract 25 mg + rutoside 50 mg + hesperidin 50 mg + Rosa canina extract 250 mg + acerola extract 50 mg tablet, 31 |
ascorbic acid 400 mg + calcium ascorbate dihydrate 400 mg + sodium ascorbate 350 mg + citrus bioflavonoids extract 25 mg + rutoside 50 mg + hesperidin 50 mg + dog rose 250 mg + acerola 50 mg tablet, 62 |
ascorbic acid 400 mg + calcium ascorbate dihydrate 400 mg + sodium ascorbate 350 mg + citrus bioflavonoids extract 25 mg + rutoside 50 mg + hesperidin 50 mg + Rosa canina extract 250 mg + acerola extract 50 mg tablet, 62 |
acetate |
sodium acetate |
sodium chloride + potassium chloride + calcium chloride dihydrate + magnesium chloride + acetate + citric acid |
sodium chloride + potassium chloride + calcium chloride + magnesium chloride + acetate + citric acid |
aciclovir 200 mg dispersible tablet, 25 |
aciclovir 200 mg tablet, 25 tablets (medicinal product pack) |
aciclovir 400 mg dispersible tablet |
aciclovir 400 mg tablet |
aciclovir 400 mg dispersible tablet, 100 |
aciclovir 400 mg tablet, 100 |
aciclovir 400 mg dispersible tablet, 70 |
aciclovir 400 mg tablet, 70 |
aciclovir 800 mg dispersible tablet, 120 |
aciclovir 800 mg tablet, 120 |
aciclovir 800 mg dispersible tablet, 5 |
aciclovir 800 mg tablet, 5 |
aclidinium + formoterol (eformoterol) fumarate dihydrate |
aclidinium + formoterol |
adalimumab 40 mg / 0.4 mL injection, 0.4 mL injection device (medicinal product unit of use) |
Unknown Cell Type 2 |
adalimumab 40 mg / 0.4 mL injection, 2 x 0.4 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 40 mg / 0.4 mL injection, 4 x 0.4 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 40 mg / 0.4 mL injection, 6 x 0.4 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, cartridge |
adalimumab 40 mg/0.8 mL injection, pen device |
adalimumab 40 mg / 0.8 mL injection, 0.8 mL injection device (medicinal product unit of use) |
Unknown Cell Type 2 |
adalimumab 40 mg / 0.8 mL injection, 1 x 0.8 mL injection device (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges |
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices |
adalimumab 40 mg / 0.8 mL injection, 2 x 0.8 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 40 mg / 0.8 mL injection, 3 x 0.8 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 40 mg / 0.8 mL injection, 4 x 0.8 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, 6 x 0.8 mL cartridges |
adalimumab 40 mg/0.8 mL injection, 6 x 0.8 mL pen devices |
adalimumab 40 mg / 0.8 mL injection, 6 x 0.8 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL injection devices |
Unknown Cell Type 2 |
adalimumab 40 mg/0.4 mL injection, 4 x 0.4 mL injection devices |
Unknown Cell Type 2 |
adalimumab 40 mg/0.4 mL injection, 6 x 0.4 mL injection devices |
Unknown Cell Type 2 |
adalimumab 40 mg/0.4 mL injection, injection device |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, 0.8 mL injection device |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL injection devices |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, 3 x 0.8 mL injection devices |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, 4 x 0.8 mL injection devices |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, 6 x 0.8 mL injection devices |
Unknown Cell Type 2 |
adalimumab 40 mg/0.8 mL injection, injection device |
Unknown Cell Type 2 |
adalimumab 80 mg / 0.8 mL injection, 0.8 mL injection device (medicinal product unit of use) |
Unknown Cell Type 2 |
adalimumab 80 mg / 0.8 mL injection, 1 x 0.8 mL injection device (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 80 mg / 0.8 mL injection, 3 x 0.8 mL injection devices (medicinal product pack) |
Unknown Cell Type 2 |
adalimumab 80 mg/0.8 mL injection, 0.8 mL injection device |
Unknown Cell Type 2 |
adalimumab 80 mg/0.8 mL injection, 3 x 0.8 mL injection devices |
Unknown Cell Type 2 |
adalimumab 80 mg/0.8 mL injection, injection device |
Unknown Cell Type 2 |
adrenaline (epinephrine) 150 microgram/0.15 mL injection, 0.15 mL injection device |
Unknown Cell Type 2 |
adrenaline (epinephrine) 150 microgram/0.15 mL injection, injection device |
Unknown Cell Type 2 |
adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
adrenaline (epinephrine) 150 microgram/0.3 mL injection, 2 x 0.3 mL injection devices |
Unknown Cell Type 2 |
adrenaline (epinephrine) 150 microgram/0.3 mL injection, injection device |
Unknown Cell Type 2 |
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 2 x 0.3 mL injection devices |
Unknown Cell Type 2 |
adrenaline (epinephrine) 300 microgram/0.3 mL injection, injection device |
Unknown Cell Type 2 |